Opin vísindi

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation

Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation


Titill: Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation
Höfundur: Djos, Anna
Treis, Diana
Fransson, Susanne
Murkes, Lena Gordon
Wessman, Sandra
Ásmundsson, Jurate
Markstrom, Agneta
Kogner, Per
Martinsson, Tommy
Útgáfa: 2022-09-19
Tungumál: Enska
Umfang: 3632229
Deild: Clinical Laboratory Services, Diagnostics and Blood Bank
Birtist í: Diagnostics (Basel, Switzerland); 12(9)
ISSN: 2075-4418
DOI: 10.3390/diagnostics12092260
Efnisorð: Meinafræði; ALK; PHOX2B; neuroblastoma; neurocristopathies; Clinical Biochemistry
URI: https://hdl.handle.net/20.500.11815/3845

Skoða fulla færslu

Tilvitnun:

Djos , A , Treis , D , Fransson , S , Murkes , L G , Wessman , S , Ásmundsson , J , Markstrom , A , Kogner , P & Martinsson , T 2022 , ' Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation ' , Diagnostics (Basel, Switzerland) , vol. 12 , no. 9 , 2260 . https://doi.org/10.3390/diagnostics12092260

Útdráttur:

A preterm infant with central hypoventilation was diagnosed with multifocal neuroblastoma. Congenital anomalies of the autonomic nervous system in association with neuroblastoma are commonly associated with germline mutations in PHOX2B. Further, the ALK gene is frequently mutated in both familial and sporadic neuroblastoma. Sanger sequencing of ALK and PHOX2B, SNP microarray of three tumor samples and whole genome sequencing of tumor and blood were performed. Genetic testing revealed a germline ALK F1174I mutation that was present in all tumor samples as well as in normal tissue samples from the patient. Neither of the patient’s parents presented the ALK variant. Array profiling of the three tumor samples showed that two of them had only numerical aberrations, whereas one sample displayed segmental alterations, including a gain at chromosome 2p, resulting in two copies of the ALK-mutated allele. Whole genome sequencing confirmed the presence of the ALK variant and did not detect any aberrations in the coding or promotor region of PHOX2B. This study is to our knowledge the first to report a de novo ALK F1174I germline mutation. This may not only predispose to congenital multifocal neuroblastoma but may also contribute to the respiratory dysfunction seen in this patient.

Athugasemdir:

Funding Information: This work has been supported by grants from the Swedish Cancer Society (TM 15-794; TM 20-1213; PK 19-566), the Swedish Childhood Cancer Foundation (TM 16-147; TM 17-166; TM 19-139; PK 17-122; SF 15-61, 18-99; DT 12-002, NC12-0026), the Swedish Research Council (TM 521-2014-3031), the Swedish state under the LUA/ALF agreement (TM ALFGBG-447171) and the Swedish Foundation for Strategic Research (TM/PK RB13-0204, www.nnbcr.se). SF was the recipient of a Research Assistant Fellowship (14-64), by the Swedish Childhood Cancer Foundation. Publisher Copyright: © 2022 by the authors.

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: